Revolution Medicines Ownership | Who Owns Revolution Medicines?
Revolution Medicines Ownership Summary
Revolution Medicines is owned by 101.32% institutional investors, 2.01% insiders. Vanguard group is the largest institutional shareholder, holding 10.25% of RVMD shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.82% of its assets in Revolution Medicines shares.
RVMD Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Revolution Medicines | 101.32% | 2.01% | -3.34% |
| Sector | Healthcare Stocks | 488.30% | 11.08% | -399.38% |
| Industry | Biotech Stocks | 307.10% | 11.11% | -218.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 17.10M | 10.25% | $747.80M |
| Farallon capital management | 14.33M | 7.61% | $527.04M |
| Wellington management group llp | 10.82M | 6.49% | $473.34M |
| Janus henderson group | 9.48M | 5.68% | $414.78M |
| Baker bros. advisors lp | 9.36M | 4.98% | $344.54M |
| Blackrock funding, inc. /de | 8.66M | 4.60% | $318.65M |
| Nextech invest | 7.60M | 4.56% | $332.47M |
| Fmr | 6.74M | 4.04% | $294.90M |
| Price t rowe associates inc /md/ | 5.87M | 3.52% | $256.58M |
| Paradigm biocapital advisors lp | 6.18M | 3.28% | $218.46M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Mass general brigham | 338.19K | 63.90% | $13.13M |
| Nextech invest | 7.60M | 53.94% | $332.47M |
| Lunate rsc | 2.20M | 45.54% | $96.06M |
| Ah capital management | 2.75M | 32.32% | $101.12M |
| Paradigm biocapital advisors lp | 6.18M | 10.01% | $218.46M |
| Casdin capital | 2.89M | 9.68% | $106.25M |
| Boxer capital | 4.28M | 8.75% | $166.09M |
| Checkpoint capital | 392.01K | 7.61% | $13.86M |
| Alphabet | 4.13M | 7.12% | $152.06M |
| Logos global management lp | 1.70M | 6.92% | $62.54M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Janus henderson group | 9.48M | 0.21% | 3.35M |
| T. rowe price investment management | 4.69M | 0.11% | 3.02M |
| Lunate rsc | 2.20M | 45.54% | 2.20M |
| Vanguard group | 17.10M | 0.01% | 2.19M |
| Norges bank | 1.74M | 0.01% | 1.74M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock funding, inc. /de | 8.66M | 0.01% | -6.03M |
| Balyasny asset management | - | - | -1.30M |
| Casdin capital | 2.89M | 9.68% | -810.00K |
| Finepoint capital lp | - | - | -691.26K |
| Perceptive advisors | - | - | -618.88K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Lunate rsc | 2.20M | 45.54% | 2.20M | $96.06M |
| Norges bank | 1.74M | 0.01% | 1.74M | $76.20M |
| Vestal point capital, lp | 1.20M | 2.32% | 1.20M | $44.15M |
| Caligan partners lp | 465.00K | 3.43% | 465.00K | $16.44M |
| Weiss asset management lp | 303.77K | 0.13% | 303.77K | $11.18M |
Sold Out
| Holder | Change |
|---|---|
| Tfc financial management | -1.00 |
| American capital advisory | -6.00 |
| Principal securities | -8.00 |
| Wolff wiese magana | -9.00 |
| Bokf, na | -10.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 318 | 8.53% | 190,637,976 | -0.22% | 101 | 0.98% | 170 | 18.06% | 89 | - |
| Mar 31, 2025 | 25 | -91.50% | 35,140,611 | -81.80% | 18 | 0.14% | 15 | -92.11% | 6 | -89.09% |
| Dec 31, 2024 | 277 | 5.73% | 184,740,316 | 9.37% | 110 | 1.08% | 179 | 20.95% | 52 | -16.13% |
| Sep 30, 2024 | 260 | 14.54% | 168,886,065 | 0.30% | 101 | 973278.73% | 148 | 18.40% | 62 | 8.77% |
| Jun 30, 2024 | 227 | 4.13% | 168,384,927 | 6.00% | - | 1101.87% | 125 | 20.19% | 57 | -13.64% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 5.28M | 2.82% | -110.56K |
| Vanguard US Total Market Shares ETF | 4.74M | 2.55% | 4.24K |
| BB Biotech AG Ord | 4.37M | 2.37% | -484.46K |
| iShares Russell 2000 ETF | 4.27M | 2.29% | - |
| Vanguard Small Cap Index | 4.07M | 2.18% | -22.59K |
| Vanguard Health Care Inv | 3.87M | 2.08% | -946.03K |
| Fidelity Growth Compy Commingled Pl S | 3.27M | 1.75% | 207.40K |
| Janus Inst Mid Cap Growth CF | 2.40M | 1.29% | 377.18K |
| Janus Henderson Enterprise D | 2.40M | 1.29% | - |
| Fidelity Growth Company Fund | 2.40M | 1.28% | 142.40K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 13, 2025 | Kelsey Stephen Michael | See Remarks | Sell | $1.21M |
| Sep 24, 2025 | Cislini Jeff | General Counsel | Sell | $79.62K |
| Sep 16, 2025 | Wei Lin | Chief Medical Officer | Sell | $98.98K |
| Sep 16, 2025 | Kelsey Stephen Michael | See Remarks | Sell | $245.94K |
| Sep 16, 2025 | GOLDSMITH MARK A | See Remarks | Sell | $614.56K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | 1 |
| 2025 Q3 | - | 13 |
| 2025 Q2 | - | 7 |
| 2025 Q1 | - | 7 |
| 2024 Q4 | 2 | 23 |
RVMD Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools